Clinical Trial Update: Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy [Phase 1]

View source ↗

Summary

This is a Phase I trial evaluating atezolizumab with interleukin-12 gene therapy in metastatic non-small cell lung cancer that progressed after first-line immun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (Tecentriq) (atezolizumab)
• IL-12 gene therapy (interleukin-12 gene therapy)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED